Fite staining showed rare clusters of AFB within the granulomas. The postoperative course was complicated by a multiloculated left pleural effusion. AFB smear of pleural fl uid obtained from video-assisted thoracoscopy showed 1-5 bacilli per high power fi eld. Cultures of lung tissue and pleural fl uid grew mycobacteria initially identifi ed as M. fortuitum group but subsequently identifi ed as M. mageritense by PCR followed by restriction enzyme analysis of the 65-kDa heat-shock protein (hsp65) (6) . Results of susceptibility testing by broth microdilution are shown in the Table. Testing for Wegener granulomatosis by antineutrophilic cytoplasmic and myeloperoxidase antibody yielded negative results. Imipenem and amikacin were prescribed, and gradual resolution of clinical signs and symptoms was observed. Oral linezolid and trimethoprim/sulfamethoxazole were prescribed at discharge. Chest radiographs taken 4 months after the open lung biopsy showed resolution of the masses.
The isolate was a nonpigmented RGM that matched the American Type Culture Collection (Manassas, VA, USA) type strain and 10 published clinical isolates of M. mageritense by PCR restriction enzyme analysis of the 65-kDa hsp gene (6) . By gene sequencing of region V of the RNA polymerase (rpoB) gene, it exhibited 99.7% identity to the GenBank type strain sequence of M. mageritense (acceptable interspecies relatedness for this sequence is >98.5% identity) (8) . The most closely related species determined by using this sequence and previously submitted sequences were other M. fortuitum species: M. porcinum (94% sequence identity), M. wolinskyi (94%), and M. peregrinum (93%).
Susceptibility testing of 23 clinical isolates of M. mageritense from the United States previously submitted to the Mycobacteria/Nocardia Research Laboratory (University of Texas Health Science Center, Tyler, TX, USA) and identifi ed by hsp65 PCR restriction analysis (6,7) was performed (Table) . These results confi rmed the potential utility of the drugs used in this case for future cases.
M. mageritense has not been reported as a cause of pulmonary (9) . Her therapeutic response also supports a cause-and-effect relationship.
The identity of an RGM isolate as M. mageritense may be suspected by its unusual antimicrobial drug susceptibility pattern, which showed an intermediate MIC to amikacin and resistance to clarithromycin at 3 days (Table) . However, defi nitive identifi cation requires molecular methods. Previous studies have shown that M. mageritense contains an inducible erythromycin methylase gene (erm 40) that confers macrolide resistance (10) . The use of molecular studies and greater attention to susceptibility patterns should enable increased recognition of M. mageritense as a human pathogen.
